Ockham Research
Ockham Research
Send Message
Ockham Research
Stop FollowingOckham Research
View as an RSS Feed
View Ockham Research's Articles BY TICKER:
AA,
AAMRQ.PK,
AAPL,
ABT,
ABX,
ADI,
AES,
AGN,
AHBIF.PK,
AIG,
ALGN,
AMAT,
AMGN,
AMZN,
AN,
ANF,
APC,
APKT,
APOL,
ASBC,
ATVI,
AVP,
AXP,
AZO,
BA,
BAC,
BBI,
BBRY,
BBT,
BBY,
BEAM,
BEZ,
BGPIQ.PK,
BIG,
BIIB,
BJ,
BK,
BKC,
BKS,
BLUD,
BMY,
BP,
BRCD,
BSX,
BTU,
BZH,
C,
CA,
CAG,
CAL,
CAR,
CAT,
CBG,
CBS,
CBST,
CELG,
CEPH,
CHK,
CKR,
CKXE,
CMCSA,
CMI,
CNW,
COST,
CPB,
CPKI,
CQB,
CREE,
CRM,
CRUS,
CSCO,
CSTR,
CTAS,
CTL,
CTSH,
CVS,
CVX,
CYB,
DB,
DDC,
DE,
DELL,
DGX,
DHI,
DIA,
DIN,
DISCA,
DISH,
DKS,
DLM,
DPZ,
DRYS,
DTG,
DV,
DVN,
DWA,
EA,
EAT,
EBAY,
EHTH,
EKDKQ.PK,
EL,
ELX,
EQR,
EQT,
ESI,
ETH,
ETP,
EWBC,
EXPE,
F,
FAST,
FDX,
FIATY.PK,
FITB,
FLR,
FMCC.OB,
FNMA.OB,
FRBK,
FSLR,
GAS,
GE,
GILD,
GIS,
GLD,
GM,
GMA,
GMCR,
GME,
GNW,
GOOG,
GPC,
GPS,
GRMN,
GS,
HCBK,
HD,
HOG,
HON,
HOTT,
HOV,
HPQ,
HRB,
HRS,
HSH,
HSY,
HUM,
IBM,
IMAX,
ING,
INTC,
INTU,
IP,
IR,
ISIS,
ITRI,
JAVA,
JCP,
JDSU,
JEF,
JHTXQ.PK,
JNJ,
JOSB,
JOY,
JPM,
K,
KIM,
KMX,
KO,
KR,
LEH,
LEN,
LGF,
LMT,
LNCR,
LOW,
LUK,
LVS,
LZB,
M,
MAS,
MBI,
MCD,
MCK,
MDLZ,
MDT,
MFA,
MMM,
MNRO,
MNST,
MON,
MOV,
MRVL,
MS,
MSFT,
MW,
NFLX,
NKE,
NOC,
NOK,
NS,
NSC,
NTAP,
NTY,
NWL,
ODP,
OHB,
OMG,
ORCL,
OSK,
OXM,
PALM,
PAYX,
PBG,
PBR,
PBT,
PBY,
PCLN,
PEP,
PETM,
PFE,
PG,
PHM,
PLL,
PNRA,
POT,
PPC,
PSA,
PTV,
PVH,
PWR,
QCOM,
QDEL,
QSII,
RAD,
RHI,
RL,
ROST,
RS,
RSH,
RTK,
S,
SAI,
SAN,
SBMRY.PK,
SBUX,
SCHW,
SEPR,
SHLD,
SLB,
SNDK,
SONC,
SPIL,
SPWR,
STI,
STLD,
STT,
STZ,
SUN,
SVNT,
SVU,
SWHC,
SWKS,
SYBT,
T,
TAP,
TASR,
TDG,
TGT,
THO,
THQIQ.OB,
THS,
TIF,
TIN,
TIVO,
TLAB,
TLB,
TM,
TOL,
TRK,
TRLG,
TROW,
TSCO,
TSN,
TSRA,
TTWO,
TUP,
TXN,
TXT,
UPS,
URS,
UTX,
VFC,
VMC,
VRX,
VVC,
VZ,
WAG,
WEN,
WFC,
WFM,
WHR,
WLP,
WMG,
WMIH.PK,
WMT,
WPO,
WSM,
WSO,
WTW,
WYN,
WYNN,
X,
XOM,
YRCW,
YUM,
ZLC
- Immucor: Profit Beats but Stock Slumps
- The Two Faces of RIM: How Do You Read It?
- Jos. A. Bank Looks Dandy Crossing $1B Market Cap
- Chiquita Brands: Don’t Go Bananas Over 1Q Warning
- SAIC Disappoints on Quarter and Guidance
- eHealth: Less Commission After Reform
- Oxford Industries Weighed Down by Guidance
- Time to Ring the Register on Boeing?
- Fabulous Fourth Quarter Boosts Best Buy
- Paychex May Pay Off for Investors
- Income Investors Perk Up to Starbucks
- Lions Gate: Worth More Than Icahn’s Offering
-
Trust Me…I Write a Blog
on Wed, Mar 24, 2010 • 4 Comments
- Bove Caves to Clients on Citi Rating
- Nike: Should Investors Sprint to Buy or Stand Pat?
- Dr. Market's Prescription for Healthcare: Rose-Colored Glasses
- Cintas: How High Will It Go?
- Palm Gets Slapped With $0 Price Target
- GameStop Surges and Proves It Is No Blockbuster
- Debt Reduction Propels Temple-Inland
- Dark Clouds Hang Over WellPoint
- Tiger Woods Announcement Boosts CBS
- Time’s Up for Movado: Overvaluation Exposed
- Cramer: Medicis Pharmaceuticals Looks Attractive
- Technical Strategist: Trouble Brewing Because of FedEx’s Chart
- Investors May Want to Give a Toast to PepsiCo
- Terra Industries Eventually Found Its Dance Partner
-
Foreshadowing Rising Taxes
on Thu, Mar 11, 2010 • Comment!
- IMAX’s Valuation Is in Fantasy Land
- Allergan Gets FDA Approval: Botox Has a Medical Use?
- Fortune Brands Sells Cobra to Puma AG
- Cramer Abandons Ship on Blue Chip Oil Stocks
